Abstract: Phosphothreonine (pThr) was found to constitute an ew class of chiral phosphoric acid (CPA) catalyst upon insertion into peptides.T od emonstrate the potential of these phosphopeptides as asymmetric catalysts,e nantioselective transfer hydrogenations of ap reviously underexplored substrate class for CPA-catalyzed reductions were carried out. pThr-containing peptides lead to the observation of enantioselectivities of up to 94:6 e.r. with 2-substituted quinolines containing C8-amino functionality.N MR studies indicate that hydrogen-bonding interactions promote strong complexation between substrates and arigid b-turn catalyst.
Few organocatalytic systems have been demonstrated to be as versatile in the realm of asymmetric synthesis as chiral phosphoric acids ( Figure 1 ). Their prowess as chiral Brønsted acids and chiral counterions has been demonstrated over aremarkable range of enantioselective reactions of interest to synthetic chemists. [1] In parallel, but seemingly unrelated, the phosphorylation of proteinogenic amino acids,i ncluding threonine (1) , has emerged as ap ost-translational modification of proteins with an ever-expanding list of functions of biochemical significance. [2, 3] In our laboratory,wecontinue to study the interfaces of biochemically important building blocks and structures for their capacity to influence fundamentally interesting stereoselective reactions. [4] In this study, we report the enantioselective transfer hydrogenation of 8-aminoquinolines [5, 6] mediated by phosphothreonine (pThr)-containing peptides with the NADH-like dihydropyridine reductant Hantzsch ester hydride (HEH).
Among the myriad of reported asymmetric chiral phosphoric acid (CPA) catalysts,t he pioneering C 2 -symmetric BINOL-derived catalytic scaffold (2), independently reported by Akiyama and Terada in 2004, has dominated the field. [7] Important variations on this substructure (3-4) complement this impressive record (Figure 1a) , [8] but C 2 -symmetry is ap ervasive feature.I ndeed, ar adical departure from these established design principles has remained elusive. Acatalyst framework that is not limited to C 2 -symmetry could be particularly important, especially if catalysts in this family are to be applied to the selective derivatization of complex molecules. [9] In constructing an ovel pThr-containing CPA, we faced two primary challenges.First, the lack of C 2 -symmetry of pThr precludes the equivalencyo ft he two free P À Ob onds, between which the acidic proton can rapidly tautomerize (Figure 1b) . Second, without the two phenolic hydroxy groups tied into aB INOL-like ring, free rotation about the pThr PÀObond is enabled (Figure 1c ). Both of these factors can produce numerous chemically distinct acid catalyst conformations,e ach exhibiting different intrinsic reaction selectivities.Nonetheless,wewondered whether pThr embedded within aw ell-defined peptide framework might lead to the observation of selective reactions,p erhaps through bifunctional catalysis. [10] We chose to test these concepts with pThr-containing peptides (5,S cheme 1) as catalysts for the transfer hydrogenation of quinolines,s ince CPAs have been shown to mediate the reduction of variously functionalized quinolines with high yields and selectivity. [5] Initial reaction development commenced with 2-substituted quinolines with C8-amino functionality owing to 1) their underexplored nature in the field of asymmetric heterocycle reduction, [6] 2) their presence in many bioactive agents, [11] and 3) our previously observed results wherein appropriately functionalized amines often lead to effective catalyst-substrate interactions in peptidemediated asymmetric reactions.
[12]
Thesynthesis of catalysts of type 5 followed conventional peptide synthesis techniques,w ith an otable BOP-mediated coupling of the free side-chain monobasic phosphoric acid (Fmoc-pThr(Bn)-OH) to peptide sequences of interest. [13] As shown in Table 1 , avariety of pThr-containing peptides were found to catalyze the reduction of 6a to 7a with high conversion and good enantiomeric ratio (e.r.). Starting with a b-turn-promoting sequence of l-o rd-Pro-Aib-XXXOMe, [14] we were intrigued to find that catalysts with either l-Pro (5a)o rd-Pro (5b)a tt he i + 1p osition produced the same enantiomer of 7a,a lbeit with higher selectivity for dPro (Table 1 , entries 1a nd 2). [15] We next turned to the i + 2 position, where we observed that utilization of 1-aminocyclopropane carboxylic acid (Acpc; 5c)r esulted in an increase in enantioselectivity (79:21 e.r.;T able 1, entry 3), which could potentially be the result of Acpc affecting the overall conformation or rigidity of the b-turn scaffold. [16] Exchanging the C-terminal methyl ester for ad imethyl amide (5d)l ed to ad rop in e.r. (70:30 e.r.;T able 1, entry 4). While extensive variation of the the i + 3r esidue did not drastically affect selectivity,itdid reveal that Met (5e)was the most effective,r esulting in 82:18 e.r. (Table 1 , entry 5). The sulfur atom of Met is not critical since the carbon isostere of Met, norleucine (Nle), was synthesized (5f)a nd behaves similarly to 5e (80:20 e.r.;T able 1, entry 6). Thestereochemistry of the i + 3r esidue exerts as mall effect on selectivity since catalyst 5g (with d-Leu in place of l-Leu at i + 3) leads to the formation of product with 82:18 e.r. (Table 1 Since the pThr-containing catalysts represent adeparture from C 2 -symmetric CPAs,w ew ished to carry out adirect comparison to an established catalyst. We observed that (R)-TRIP (2a), ac atalyst previously reported for 3-aminoquinoline reductions,a ffords 7a with 14:86 e.r.,t hus revealing that ap Thr-containing catalyst offers aslightly lower but still comparable e.r. in this case (entry 12).
[5h] Inter- ii)The chemical shift of the NH Met signal (red) remains constant,w hich is characteristic of a b-turn H-bond with the pThr C=O. iii)For 6b,l arge downfield shifts are observed for the C7 (blue) and C4 (purple) protons,t hus suggesting the formation of a 5e-6b salt. iv) Al arge downfield shift of the C8 NÀH (green) is further evidence for the protonation of 6b,a swell as potentialc omplexation between this NÀHa nd 5e.d )5e and HEH (1:9 stoichiometry) in CD 2 Cl 2 .T he same trends are observed for 5e as above. [18] e) Speculativee nsemble of potentiali nteractions between substrates and catalyst. Protons in purple are believed to be engaged in hydrogen-bonding interactions.
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With catalyst 5e in hand, we turned our attention to substrate scope,a nd the catalyst was found to function well for substrates with variations at the 8-position (Table 2) . For example,b enzylic ureas (6b-6f)l ed to products with up to 92:8 e.r. at RT (Table 2 , entries 3, 5, 7, 9, and 11), while aliphatic ureas (6g-6i)are also tolerated (Table 2, entries 13, 15, 17) . Lowering the temperature to 4 8 8Cl ed to increases in e.r. in many cases (e.g., 94:6 e.r.;T able 2, entries 4, 6, 8, and 10), although extended reaction times were generally required. Parenthetically,i nt he case of 6f,w eobserved that the pThr peptide delivers as lightly higher e.r. than the (R)-TRIP catalyst 2a (13:87 e.r. for 6f over 24 h). Aliphatic substitution at the quinoline C2-position (6j-6k)l ed to products with lower e.r. for reasons that are not fully understood (Table 2 , entries [19] [20] . Finally,e xchange of the urea for acetamide (6l)a nd carbamate (6m)r esulted in slower reaction rates but similar and even higher e.r. compared to isostere 6a( Table 2 , entries 21-22).The absolute stereochemistry of the major product was determined explicitly for compound 7fby X-ray crystallography. [17] We have begun to study the possible mechanism of action of the pThr-containing peptides by examining the 1 HNMR chemical shifts upon mixing peptide 5e with substrate 6b or HEH (Figure 2a-d) . On the one hand, these additives have little effect on the shift of the i + 3N H Met signal (Figure 2 , red). Since this resonance is characteristic of a10-membered ring intramolecular H-bond with the pThr C = O( ab-turn), the addition of the substrates may not perturb this key catalyst secondary structural feature.O nt he other hand, the NH pThr signal (Figure 2 , yellow) appears to broaden significantly and that of i + 2N H Acpc (Figure 2 , orange) shifts downfield in the presence of either 6b or HEH, thus suggesting the formation of intermolecular interactions (e.g, through H-bonding) between the catalyst and substrates.D ownfield shifts are also observed for the quinoline C7 (blue) and C4 (purple) proton signals,a sw ell as for aq uinoline urea NÀHs ignal. These chemical shift perturbations are consistent with salt formation between 5e and 6b. [19] Thed ownfield shift of aq uinoline C8 N À H signal (Figure 2 , green) could also be ascribed to an H-bond with 5e. Further evidence for this H-bond was revealed through the reduction of 2-methylquinoline with 5e,since the lack of directing group yields product with only 58:42 e.r..T aken together,t hese observations support ar eaction for which enantioselectivity derives from the formation of noncovalent interactions between 6 and the b-turn peptide catalyst 5e (Figure 2e ).
In conclusion, we report the development of pThr-containing peptides as aC PA scaffold. Strikingly,t his framework, which lacks the C 2 -symmetry of better known CPAscaffolds,isable to overcome the existence of both non-equivalent tautomeric states and the many rotatable bonds extant within the catalyst. It achieves this selectivity through interactions with the substrates in the context of the peptide secondary structure.The pThr catalyst tolerates ar ange of functionality at the C8-urea and the C2-position of the quinoline,and is able to deliver substrates with e.r. up to 94:6 e.r..G iven the remarkable range of chemical reactions that may be catalyzed with chiral CPAs,w ea re hopeful that these new pThr-based catalysts will have significant utility as asymmetric catalysts,p erhaps especially in the realm of chemical operations on complex substrates.
